Shekman Wong

4.4k total citations · 1 hit paper
65 papers, 3.3k citations indexed

About

Shekman Wong is a scholar working on Oncology, Genetics and Pharmacology. According to data from OpenAlex, Shekman Wong has authored 65 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Genetics and 15 papers in Pharmacology. Recurrent topics in Shekman Wong's work include Chronic Lymphocytic Leukemia Research (17 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Shekman Wong is often cited by papers focused on Chronic Lymphocytic Leukemia Research (17 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Shekman Wong collaborates with scholars based in United States, Egypt and United Kingdom. Shekman Wong's co-authors include Rod Humerickhouse, Martin Dunbar, Ahmed Hamed Salem, Ronald J. Sawchuk, Suresh Agarwal, Soham D. Puvvada, Sari H. Enschede, Ming Zhu, Monali Desai and Elisa Cerri and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Shekman Wong

64 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia

2015 1.3k citations Andrew W. Roberts, Matthew S. Davids et al. New England Journal of Medicine profile →

Peers

Shekman Wong

GENET

HEMAT

PFM

ONCOL

Y Morishima Japan

Shinichi Kawai Japan

Patrick D. Walker United States

Lionel D. Lewis United States

Hisashi Tsurumi Japan

Hannah A. Blair New Zealand

Akinobu Hamada Japan

John M. Kovarik Switzerland

Curt Peterson Sweden

Yi‐Lin Chiu United States

Y Morishima Japan

Shekman Wong

596 ×0.4

GENET

1.1k ×1.2

2.5k ×3.0

HEMAT

602 ×0.7

PFM

1.1k ×1.5

ONCOL

Citations per year, relative to Shekman Wong Shekman Wong (= 1×) peers Y Morishima

Countries citing papers authored by Shekman Wong

Since Specialization

Citations

This map shows the geographic impact of Shekman Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shekman Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shekman Wong more than expected).

Fields of papers citing papers by Shekman Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shekman Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shekman Wong. The network helps show where Shekman Wong may publish in the future.

Co-authorship network of co-authors of Shekman Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Shekman Wong. A scholar is included among the top collaborators of Shekman Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shekman Wong. Shekman Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strickler, John H., Patricia LoRusso, Ravi Salgia, et al.. (2020). Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors. Molecular Cancer Therapeutics. 19(5). 1210–1217. 21 indexed citations

Vij, Ravi, Rajneesh Nath, Daniel Afar, et al.. (2020). First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma. Clinical Cancer Research. 26(10). 2308–2317. 24 indexed citations

Freise, Kevin J., et al.. (2016). Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure–response analysis. Cancer Chemotherapy and Pharmacology. 78(4). 847–853. 25 indexed citations

Salem, Ahmed Hamed, et al.. (2016). Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers. Clinical Drug Investigation. 37(3). 303–309. 45 indexed citations

Liu, Hong, Yanbin Lao, Katty Wan, et al.. (2016). Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites. Drug Metabolism and Disposition. 45(3). 294–305. 77 indexed citations

Freise, Kevin J., Sven Mensing, Shekman Wong, et al.. (2016). Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia. Clinical Pharmacokinetics. 56(5). 515–523. 52 indexed citations

Roberts, Andrew W., Matthew S. Davids, John M. Pagel, et al.. (2015). Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia. New England Journal of Medicine. 374(4). 311–322. 1337 indexed citations breakdown →

Wong, Shekman, Michael R. Goldberg, Charles H. Ballow, Michael M. Kitt, & Steven L. Barriere. (2010). Effect of Telavancin on the Pharmacokinetics of the Cytochrome P450 3A Probe Substrate Midazolam: A Randomized, Double‐Blind, Crossover Study in Healthy Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(2). 136–143. 17 indexed citations

Wong, Shekman, Steven L. Barriere, Michael M. Kitt, & Michael R. Goldberg. (2008). Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects. Journal of Antimicrobial Chemotherapy. 62(4). 780–783. 35 indexed citations

10.

Wong, Shekman & G. Richard Granneman. (1998). Modeling of sertindole pharmacokinetic disposition in healthy volunteers in short term dose-escalation studies. Journal of Pharmaceutical Sciences. 87(12). 1629–1631. 14 indexed citations

11.

Wong, Shekman, Stanley Menacherry, Darcy J. Mulford, et al.. (1997). Pharmacokinetics of sertindole and dehydrosertindole in volunteers with normal or impaired renal function. European Journal of Clinical Pharmacology. 52(3). 223–227. 27 indexed citations

12.

Wong, Shekman, Guoliang Cao, Randall J. Mack, & G. Richard Granneman. (1997). Pharmacokinetics of sertindole in healthy young and elderly male and female subjects*. Clinical Pharmacology & Therapeutics. 62(2). 157–164. 29 indexed citations

13.

Rodrigues, A. David & Shekman Wong. (1997). Application of Human Liver Microsomes in Metabolism-Based Drug-Drug Interactions: In Vitro-in Vivo Correlations and the Abbott Laboratories Experience. Advances in pharmacology. 43. 65–101. 27 indexed citations

14.

Wong, Shekman, et al.. (1997). The Effect of Erythromycin on the CYP3A Component of Sertindole Clearance in Healthy Volunteers. The Journal of Clinical Pharmacology. 37(11). 1056–1061. 12 indexed citations

15.

Li, Ronald C., Shekman Wong, & Keith K. H. Chan. (1995). Microcomputer-Based Programs for Pharmacokinetic Simulations. American Journal of Pharmaceutical Education. 59(2). 143–147. 30 indexed citations

16.

Wong, Shekman, Walid M. Awni, John H. Cavanaugh, et al.. (1995). The Pharmacokinetics of Single Oral Doses of Zileuton 200 to 800mg, its Enantiomers, and its Metabolites, in Normal Healthy Volunteers. Clinical Pharmacokinetics. 29(Supplement 2). 9–21. 24 indexed citations

17.

Wang, Yanfeng, Shekman Wong, & Ronald J. Sawchuk. (1993). Microdialysis Calibration Using Retrodialysis and Zero-Net Flux: Application to a Study of the Distribution of Zidovudine to Rabbit Cerebrospinal Fluid and Thalamus. Pharmaceutical Research. 10(10). 1411–1419. 139 indexed citations

18.

Wong, Shekman, Kristel Van Belle, & Ronald J. Sawchuk. (1993). Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis.. Journal of Pharmacology and Experimental Therapeutics. 264(2). 899–909. 92 indexed citations

19.

Wong, Shekman, Yanfeng Wang, & Ronald J. Sawchuk. (1992). Analysis of Zidovudine Distribution to Specific Regions in Rabbit Brain Using Microdialysis. Pharmaceutical Research. 9(3). 332–338. 64 indexed citations

20.

Wong, Shekman, et al.. (1992). Competitive Inhibition of Zidovudine Clearance by Probenecid During Continuous Coadministration. Pharmaceutical Research. 9(2). 228–235. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact